Your browser is no longer supported. Please, upgrade your browser.
Settings
AMGN Amgen Inc. daily Stock Chart
AMGN [NASD]
Amgen Inc.
IndexS&P 500 P/E17.31 EPS (ttm)12.77 Insider Own0.20% Shs Outstand590.00M Perf Week-1.69%
Market Cap130.39B Forward P/E13.07 EPS next Y16.91 Insider Trans-1.02% Shs Float587.21M Perf Month-4.29%
Income7.68B PEG2.91 EPS next Q3.82 Inst Own78.30% Short Float1.19% Perf Quarter2.74%
Sales23.97B P/S5.44 EPS this Y2.00% Inst Trans-1.04% Short Ratio2.06 Perf Half Y-5.35%
Book/sh16.08 P/B13.74 EPS next Y8.63% ROA12.80% Target Price252.21 Perf Year26.48%
Cash/sh13.58 P/C16.27 EPS next 5Y5.95% ROE75.10% 52W Range170.56 - 244.99 Perf YTD-8.33%
Dividend6.40 P/FCF24.87 EPS past 5Y14.00% ROI21.20% 52W High-9.79% Beta0.94
Dividend %2.90% Quick Ratio1.30 Sales past 5Y3.10% Gross Margin79.90% 52W Low29.57% ATR6.37
Employees23400 Current Ratio1.60 Sales Q/Q10.90% Oper. Margin39.90% RSI (14)43.93 Volatility2.48% 2.80%
OptionableYes Debt/Eq3.36 EPS Q/Q-3.40% Profit Margin32.00% Rel Volume1.07 Prev Close223.72
ShortableYes LT Debt/Eq3.16 EarningsApr 30 AMC Payout46.30% Avg Volume3.41M Price221.00
Recom2.20 SMA20-4.48% SMA50-1.35% SMA2001.19% Volume3,646,907 Change-1.22%
Apr-15-20Resumed Guggenheim Neutral
Mar-31-20Initiated Wolfe Research Peer Perform
Mar-30-20Upgrade Raymond James Mkt Perform → Outperform $255
Mar-05-20Upgrade BofA/Merrill Neutral → Buy $245 → $250
Feb-27-20Initiated Barclays Equal Weight $235
Jan-31-20Downgrade Robert W. Baird Neutral → Underperform $173 → $185
Jan-21-20Upgrade Evercore ISI In-line → Outperform
Dec-24-19Initiated Raymond James Mkt Perform
Dec-17-19Resumed Morgan Stanley Overweight $280
Nov-12-19Initiated SunTrust Buy $256
Nov-05-19Upgrade Cantor Fitzgerald Neutral → Overweight $230 → $255
Oct-17-19Resumed BofA/Merrill Neutral $215
Aug-19-19Downgrade Mizuho Buy → Neutral $208 → $212
May-23-19Upgrade Citigroup Neutral → Buy
May-21-19Initiated Credit Suisse Outperform $208
Jan-28-19Downgrade Evercore ISI Outperform → In-line
Oct-01-18Initiated Cantor Fitzgerald Neutral $223
Apr-05-18Reiterated Barclays Equal Weight $190 → $180
Feb-12-18Reiterated Mizuho Buy $192 → $200
Jan-23-18Upgrade Argus Hold → Buy
Jun-03-20 11:38AM  
Jun-02-20 09:00AM  
06:00AM  
Jun-01-20 09:53AM  
08:00AM  
07:47AM  
May-30-20 11:31AM  
May-29-20 07:38PM  
04:32PM  
12:39PM  
08:00AM  
May-28-20 05:25PM  
05:00PM  
09:27AM  
May-27-20 03:03PM  
May-26-20 05:00PM  
07:52AM  
May-20-20 07:00PM  
May-19-20 08:03AM  
May-18-20 03:37PM  
12:00PM  
May-14-20 10:46AM  
06:42AM  
May-13-20 03:45PM  
06:32AM  
May-12-20 01:36PM  
09:00AM  
May-11-20 01:23PM  
12:15PM  
09:07AM  
May-10-20 08:04AM  
May-08-20 04:24PM  
11:23AM  
08:30AM  
08:30AM  
May-07-20 11:24AM  
May-06-20 03:06PM  
02:50PM  
09:00AM  
08:19AM  
May-05-20 03:26PM  
11:50AM  
09:00AM  
07:21AM  
May-04-20 05:59PM  
05:15PM  
04:08PM  
03:12PM  
10:15AM  
May-03-20 08:19AM  
May-01-20 10:44PM  
06:28PM  
11:13AM  
10:54AM  
08:09AM  
12:31AM  
Apr-30-20 05:58PM  
05:31PM  
05:25PM  
05:21PM  
04:12PM  
04:06PM  
04:06PM  
03:30PM  
08:51AM  
Apr-29-20 10:05AM  
Apr-28-20 12:33PM  
11:18AM  
Apr-27-20 04:01PM  
12:43PM  
Apr-24-20 01:33PM  
11:30AM  
Apr-23-20 03:26PM  
01:55PM  
01:40PM  
12:32PM  
06:06AM  
Apr-22-20 11:29AM  
10:55AM  
Apr-21-20 04:21PM  
04:19PM  
07:05AM  
Apr-20-20 10:40AM  
08:15AM  
08:00AM  
05:44AM  
Apr-17-20 04:04PM  
12:40PM  
11:24AM  
10:43AM  
07:15AM  
Apr-16-20 11:18AM  
11:15AM  
07:08AM  
Apr-15-20 05:06PM  
11:32AM  
10:07AM  
08:52AM  
08:26AM  
07:22AM  
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta, a pegylated protein to treat cancer patients; Prolia to treat postmenopausal women with osteoporosis; Xgeva for skeletal-related events prevention; Aranesp to treat a lower-than-normal number of red blood cells and anemia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Sensipar/Mimpara to treat secondary hyperparathyroidism; and EPOGEN to treat anemia caused by chronic kidney disease. It also markets other products in various markets, including Nplate, Vectibix, Repatha, Parsabiv, BLINCYTO, Aimovig, NEUPOGEN, Otezla, AMGEVITA, KANJINTI, EVENITY, IMLYGIC, MVASI, and Corlanor. Amgen Inc. serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. The company has collaboration agreements with Novartis; UCB; Bayer HealthCare LLC; BeiGene, Ltd.; QIAGEN N.V.; and Adaptive Biotechnologies. Amgen Inc. was founded in 1980 and is headquartered in Thousand Oaks, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SUGAR RONALD DDirectorMay 20Option Exercise54.691,00054,69016,482May 20 09:24 PM
SUGAR RONALD DDirectorMay 20Sale229.271,000229,27015,482May 20 09:24 PM
Williams R SandersDirectorMay 06Sale237.31425100,8575,409May 07 08:49 PM
SUGAR RONALD DDirectorApr 22Option Exercise54.691,00054,69015,636Apr 22 07:07 PM
SUGAR RONALD DDirectorApr 22Sale233.351,000233,35014,636Apr 22 07:07 PM
Bradway Robert AChairman, CEO and PresidentApr 13Option Exercise58.43127,0007,420,610595,516Apr 13 07:54 PM
Piacquad DavidSVP, Business DevelopmentFeb 06Sale229.939,2642,130,07939,700Feb 07 08:25 PM
Williams R SandersDirectorFeb 06Sale233.7242599,3314,988Feb 10 09:33 PM
Meline David WEVP & CFONov 25Sale234.368,7372,047,60349,378Nov 25 06:27 PM
Graham Jonathan PEVP, Gen. Counsel & Secy.Nov 22Sale230.549,0002,074,83742,853Nov 25 06:25 PM
Piacquad DavidSVP, Business DevelopmentNov 20Option Exercise156.355,749898,85653,361Nov 20 08:09 PM
SUGAR RONALD DDirectorNov 06Option Exercise54.712,000109,42016,436Nov 07 06:20 PM
Williams R SandersDirectorNov 06Sale215.4542591,5665,413Nov 07 06:22 PM
SUGAR RONALD DDirectorNov 06Sale215.452,000430,90014,436Nov 07 06:20 PM
SUGAR RONALD DDirectorOct 02Option Exercise54.712,000109,42016,436Oct 03 05:06 PM
SUGAR RONALD DDirectorOct 02Sale193.582,000387,16014,436Oct 03 05:06 PM
SUGAR RONALD DDirectorSep 04Option Exercise54.712,000109,42016,336Sep 04 06:08 PM
SUGAR RONALD DDirectorSep 04Sale206.702,000413,40014,336Sep 04 06:08 PM
Patton Cynthia MSVP & CCOAug 30Option Exercise158.438,6241,366,33132,648Sep 04 06:07 PM
Patton Cynthia MSVP & CCOAug 30Sale208.0713,4262,793,51022,097Sep 04 06:07 PM
SUGAR RONALD DDirectorAug 07Option Exercise54.712,000109,42016,336Aug 08 07:09 PM
Williams R SandersDirectorAug 07Sale183.0442577,7925,838Aug 08 07:12 PM
SUGAR RONALD DDirectorAug 07Sale183.042,000366,08014,336Aug 08 07:09 PM
SUGAR RONALD DDirectorJul 03Option Exercise54.712,000109,42016,336Jul 08 04:23 PM
SUGAR RONALD DDirectorJul 03Sale187.582,000375,16014,336Jul 08 04:23 PM
SUGAR RONALD DDirectorJun 05Option Exercise54.712,000109,42016,219Jun 05 06:55 PM
SUGAR RONALD DDirectorJun 05Sale175.682,000351,36014,219Jun 05 06:55 PM